Functional consequences of IGFBP excess—lessons from transgenic mice

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pediatric nephrology (Berlin, West)

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00467-004-1657-zPMID 15602658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor binding protein-6 transgenic mice: postnatal growth, brain development, and reproduction abnormalities.

  2004influential reference
• Growth selection in mice reveals conserved and redundant expression patterns of the insulin-like growth factor system.

  2004cited by this paper
• Insulin-like growth factor-binding protein-4 inhibits growth of the thymus in transgenic mice.

  2004cited by this paper
• ‘Designer’ tumors in mice

  2004cited by this paper
• Reproductive abnormalities in human insulin-like growth factor-binding protein-1 transgenic male mice.

  2004cited by this paper
• Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice

  2004cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein-4 Inhibits Colony Formation of Colorectal Cancer Cells by IGF-independent Mechanisms

  2004influential reference
• Insulin‐like growth factor binding protein‐1 over‐expression in transgenic mice inhibits hepatic preneoplasia

  2003cited by this paper
• Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1.

  2003cited by this paper
• IGF-binding protein-4: biochemical characteristics and functional consequences.

  2003cited by this paper
• Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine.

  2003cited by this paper
• Perturbations in Bone Formation and Resorption in Insulin‐Like Growth Factor Binding Protein‐3 Transgenic Mice

  2003cited by this paper
• Paracrine Overexpression of IGFBP‐4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation

  2003influential reference
• Bone Formation in the Context of Growth Retardation Induced by hIGFBP-1 Overexpression in Transgenic Mice

  2002cited by this paper
• Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP‐2 in vivo

  2002cited by this paper
• Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice.

  2002cited by this paper
• Reproductive abnormalities in human IGF binding protein-1 transgenic female mice.

  2002cited by this paper
• Insulin‐like growth factor binding protein 2 (IGFBP‐2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF‐I excess on adrenocortical cells in vivo

  2002influential reference
• Functional Alteration of the Somatotrophic Axis in Transgenic Mice with Liver-Specific Expression of Human Insulin-like Growth Factor Binding Protein-1

  2002cited by this paper
• Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice.

  2002cited by this paper
• Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice

  2002influential reference
• Insights from insulin-like growth factor binding protein transgenic mice.

  2002cited by this paper
• Minireview: Insights from Insulin-Like Growth Factor Binding Protein Transgenic Mice

  2002cited by this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cited by this paper
• Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice.

  2002cited by this paper
• Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice.

  2002cited by this paper
• Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia.

  2002cited by this paper
• Essential role of PDK1 in regulating cell size and development in mice

  2002cited by this paper
• Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2.

  2001cited by this paper
• Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice.

  2001cited by this paper
• Overexpression of Human Insulin-Like Growth Factor Binding Protein-1 in the Mouse Leads to Nephron Deficit

  2001cited by this paper
• Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice.

  2001cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Growth Inhibition in Giant Growth Hormone Transgenic Mice by Overexpression of Insulin-Like Growth Factor- Binding Protein-2

  2000influential reference
• Overexpression of insulin-like growth factor binding protein-1 in transgenic mice

  2000cited by this paper
• Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance.

  2000cited by this paper
• Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene.

  2000cited by this paper
• Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1.

  2000cited by this paper
• Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland.

  2000cited by this paper
• Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1.

  2000cited by this paper
• Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice.

  1999cited by this paper
• Thyroid gland function and growth in IGF binding protein-1 transgenic mice.

  1999cited by this paper
• Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain.

  1999cited by this paper
• Enhanced gluconeogenesis and hepatic insulin resistance in insulin-like growth factor binding protein-1 transgenic mice.

  1999cited by this paper
• Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice.

  1999cited by this paper
• Overexpression of Insulin-Like Growth Factor-Binding Protein-4 (IGFBP-4) in Smooth Muscle Cells of Transgenic Mice through a Smooth Muscle α-Actin-IGFBP-4 Fusion Gene Induces Smooth Muscle Hypoplasia.

  1998cited by this paper
• Altered growth of mice divergently selected for body weight is associated with complex changes in the growth hormone/insulin-like growth factor system.

  1998cited by this paper
• Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia.

  1998cited by this paper
• Liver-Specific Expression of Human Insulin-Like Growth Factor Binding Protein-1 in Transgenic Mice: Repercussions on Reproduction, Ante- and Perinatal Mortality and Postnatal Growth.

  1997cited by this paper
• Derangements of the somatotropic hormone axis in chronic renal failure.

  1997cited by this paper
• Reduced fecundity in insulin-like growth factor-binding protein-1 transgenic mice.

  1997cited by this paper
• Impaired brain development and reduced astrocyte response to injury in transgenic mice expressing IGF binding protein-1.

  1997cited by this paper
• Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth.

  1997cited by this paper
• Islet cell proliferation and apoptosis in insulin-like growth factor binding protein-1 in transgenic mice.

  1997cited by this paper
• Expression of insulin-like growth factor binding proteins (IGFBPs) in IGFBP-1 transgenic mice.

  1997cited by this paper
• Hyperglycemia and impaired glucose tolerance in IGF binding protein-1 transgenic mice.

  1996cited by this paper
• Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model.

  1996cited by this paper
• Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.

  1996cited by this paper
• In vivo effects of insulin-like growth factor-I on the development of sensory pathways: analysis of the primary somatic sensory cortex (S1) of transgenic mice.

  1996cited by this paper
• Effects of insulin-like growth factors (IGF) on pancreatic islet function in IGF binding protein-1 transgenic mice

  1996cited by this paper
• Impaired estrogen action in the uterus of insulin-like growth factor binding protein-1 transgenic mice.

  1996cited by this paper
• Genetic approaches to the function of insulin-like growth factor-binding proteins during rodent development.

  1996cited by this paper
• Genetic ablation of IGFBP-2 suggests functional redundancy in the IGFBP family.

  1995cited by this paper
• Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons.

  1995cited by this paper
• Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice.

  1995cited by this paper
• Insulin-like growth factor-I influences the initiation of myelination: studies of the anterior commissure of transgenic mice.

  1995cited by this paper
• Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice.

  1995cited by this paper
• Insulin-like growth factor-I and insulin-like growth factor binding protein-3 inhibit involution of the mammary gland following lactation: studies in transgenic mice.

  1995cited by this paper
• In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice

  1995cited by this paper
• Expression of human insulin-like growth factor-binding protein-3 in transgenic mice.

  1995cited by this paper
• Brain growth retardation due to the expression of human insulin like growth factor binding protein-1 in transgenic mice: an in vivo model for the analysis of igf function in the brain.

  1994cited by this paper
• Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

  1993cited by this paper

• Insulin-like Growth Factor 1 (IGF1), IGF Binding Protein-3 (IGFBP3) and Growth Response to Daily Zinc Supplementation: A Randomized Trial in Rural Laotian Children

  2023cites this paper
• Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5

  2020cites this paper
• Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver

  2018cites this paper
• Investigation of IGF2, IGFBP2 and p63 proteins in rhabdomyosarcoma tumors.

  2017cites this paper
• Skeletal muscle-specific overexpression of IGFBP-2 promotes a slower muscle phenotype in healthy but not dystrophic mdx mice and does not affect the dystrophic pathology.

  2016cites this paper
• transgenic mice overexpressing IGFBP-2 glycolytic muscle metabolism in adolescent male Increased fat mass, decreased myofiber size, and a shift to

  2016cites this paper
• 16 HOURS PHOTOPERIOD IN HOLSTEIN HEIFERS IN THE SUBTROPICS: EFFECTS IN DEVELOPMENT AND AGE TO FIRST ESTRUS

  2015cites this paper
• Acute mechanical overload increases IGF-I and MMP-9 mRNA in 3D tissue-engineered skeletal muscle

  2014cites this paper
• 16 HOURS PHOTOPERIOD IN HOLSTEIN HEIFERS IN THE SUBTROPICS: EFFECTS IN DEVELOPMENT AND AGE TO FIRST ESTRUS

  2014cites this paper
• Genetic dissection of IGF1-dependent and -independent effects of permanent GH excess on postnatal growth and organ pathology of mice.

  2014cites this paper
• An in vitro model for assessment of skeletal muscle adaptation following exercise related physiological cues

  2013cites this paper
• RTEF-1 Attenuates Blood Glucose Levels by Regulating Insulin-Like Growth Factor Binding Protein-1 in the Endothelium

  2012cites this paper
• Insulin-like growth factor binding proteins and mammary gland development.

  2011cites this paper
• Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2.

  2010cites this paper
• Insulin-like growth factor binding protein-7 induces activation and transdifferentiation of hepatic stellate cells in vitro.

  2009cites this paper
• Contrasting bone effects of temporary versus permanent IGFBP administration in rodents.

  2008cites this paper
• Role of Insulin-Like Growth Factor Binding Proteins in Mammary Gland Development

  2008cites this paper
• Impaired Fertility in Transgenic Mice Overexpressing Betacellulin

  2007cites this paper
• Impaired Fertility in Transgenic Mice Overexpressing Betacellulin

  2007cites this paper
• Postnatally elevated levels of insulin-like growth factor (IGF)-II fail to rescue the dwarfism of IGF-I-deficient mice except kidney weight.

  2007cites this paper
• Insulin-like growth factors and placental function

  2007cites this paper
• PAPPA2, an Enzyme That Cleaves an Insulin-Like Growth-Factor-Binding Protein, Is a Candidate Gene for a Quantitative Trait Locus Affecting Body Size in Mice

  2006cites this paper
• PAPPA2 , an enzyme that cleaves an insulin-like growth factor binding protein, is a candidate gene for a QTL affecting body size in mice

  2006cites this paper
• Consequences of postnatal insulin-like growth factor II overexpression in insulin-like growth factor I deficient mice

  2005cites this paper